-Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis
Labò, G.; Barbara, L.; Gasbarrini, G.; Roda, E.; Schiavina, M.; Bonvicini, F.
Minerva Medica 63(75): 4055-4059
1972
ISSN/ISBN: 0026-4806 PMID: 4563998 Document Number: 54916
Document emailed within 1 workday
Related Documents
Cortinovis, A.; Paolini, F.A.; Crippa, A. 1979: Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies Minerva Medica 70(54): 3709-3713Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Surrenti, C.; Arcangeli, A.; Casini, A. 1978: The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment Minerva Medica 69(61): 4251-4256
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Melga, P.L.; Peluffo, F.; Ghiorzi, G.B.; Campostano, A.; Derchi, L. 1980: Study of the changes of some biohumoral parameters related to hepatic function. Special reference to the lipid pattern after treatment with alpha-mercaptopropionylglycine in a group of aged subjects Minerva Medica 71(32): 2273-2280
Chidoi, J.; Yanagihara, M.; Matsusaka, Y.; Hamada, K. 1963: Clinical Results with Thiola Tablets Hifuka Kiyo. Acta Dermatologica 58: 217-219
Forns Bernhardt, X. 2000: Treatment of chronic hepatitis C. Combined treatment in naive patients Gastroenterologia y Hepatologia 23(Suppl 1): 43-46
Amarapurkar, D. 2007: Role of liver biopsy in management of chronic hepatitis B and chronic hepatitis C Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 28(2): 67-68
Sherlock, S. 1980: Treatment of chronic hepatitis Annals of the Academy of Medicine Singapore 9(2): 185-187
Marcellin, P.; Asselah, T.; Ripault, M.P.; Boyer, N. 2004: Treatment of chronic hepatitis c Minerva Gastroenterologica E Dietologica 50(1): 29-36
Labayle, D.; Chapaut, J.C.; Etienne, J.P. 1978: Chronic hepatitis and its treatment La Revue du Praticien 35(25): 1915-1924
García-Tsao, G. 1995: Treatment of chronic hepatitis C Revista de Gastroenterologia de Mexico 60(4 Suppl 2: S52-S53